Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND application for first-in-human study of CPT-31

Dec. 11, 2019

IND for HLX-10 plus HLX-07 antibody combination therapy approved in China

Dec. 11, 2019

Scohia Pharma initiates phase I study of SCO-267

Dec. 11, 2019

CARsgen Therapeutics receives IND clearance for AB-011 in China

Dec. 11, 2019

Enterovirus contributes to islet autoimmunity

Dec. 11, 2019

Killer T cells protected by membrane lipid order and charge

Dec. 11, 2019

Orca opens phase Ib study of TregGraft in hematologic malignancies

Dec. 10, 2019

Sinovent studies small-molecule human URAT1 inhibitor XNW-3009 in phase I

Dec. 10, 2019

FDA removes clinical hold on Abeona's phase III VIITAL study of EB-101

Dec. 10, 2019

LAIMU synthesizes new compounds for allergy

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...